cambridge's bluebird bio licenses delivery tech to novartis, gsk..

of all car-t cell trials registered since 2001, more than half are being conducted in china..

more stories from investigations

. we have let patients down, admits senior northern ireland civil servant .

.

it's the first successful medical treatment of a human fetus for the underlying cause of a genetic disorder, experts say.

copyright © the asahi shimbun company. all rights reserved. no reproduction or republication without written permission.